J L Fdez-Morera

Publications (2)8.98 Total impact

• Article: The relationship of anti-MICA antibodies and MICA expression with heart allograft rejection.

  B Suárez-Alvarez, A López-Vázquez, M Zapico Gonzalez, J L Fdez-Morera, B Díaz-Molina, M A Blanco-Gelaz, D Pascual, J Martínez-Borra, M Muro, M R Alvarez-López, C López-Larrea
  [show abstract] [hide abstract]
  ABSTRACT: The role of MICA antibodies in acute heart allograft rejection was examined utilizing 190 pre- and post-transplant serum samples from 44 patients collected during the first year after transplantation. MICA antibodies were detected by CDC test on recombinant cell lines and by the newly developed Luminex MICA antibody detection assay. Additionally, MICA expression was analyzed by 'real time' RT-PCR and by immunohistochemistry in 10 endomyocardial biopsies. Only two subjects had HLA antibodies post-transplant. Nevertheless, MICA antibodies were found in a significant number of subjects. The prevalence of MICA antibodies was significantly higher among those with severe acute rejection (AR) than in those without rejection (60.7% vs. 14.3%, p = 0.0038 by CDC; 55.5% vs. 5.7%, p = 0.0020 by Luminex). In most cases, the appearance of MICA antibodies post-transplant precedes AR. Following transplantation, MICA up-regulation correlated with histological evidence of severe rejection. Monitoring for MICA antibodies post-transplant may be useful to establish new risk factors for acute rejection.
  American Journal of Transplantation 08/2007; 7(7):1842-8. · 6.39 Impact Factor
• Article: Clinical behavior of multiple sclerosis is modulated by the MHC class I-chain-related gene A.

  J L Fdez-Morera, A Tunon, S Rodriguez-Rodero, L Rodrigo, J Martinez-Borra, S Gonzalez, A Lopez-Vazquez, C H Lahoz, C Lopez-Larrea
  [show abstract] [hide abstract]
  ABSTRACT: It is well known that certain HLA class II alleles confer an increased risk for developing multiple sclerosis (MS). Recent studies have suggested HLA class I as a region that may also contribute to the development of MS. In this study, we investigated the association between HLA-DR, HLA-B alleles, and major histocompatibility complex (MHC) class I-chain-related gene A (MICA) transmembrane (MICA-TM) polymorphisms and disease progression in 104 MS patients and 116 healthy controls. DR1 was found to be decreased in patients when compared with controls (p(c) = 0.012). Neither HLA-B nor HLA-DR alleles were found to be associated with MS susceptibility. Furthermore, the prevalence of MICA-A5 in patients with relapsing MS was 9% while the prevalence in progressive forms was 42% (p(c) = 0.0015). The extended haplotypes related to MICA-TM5 that were found in our population were DR7-MICA5-B64 (EH 64.1, delta(s) = 0.38), DR4-MICA5-B62 (EH 62.1, delta(s) = 0.28), and DR11-MICA5-B35 (EH35.1, delta(s) = 0.10), but none of them were found to be associated to MS susceptibility or disease progression. Our data could indicate a possible role of MICA-TM in MS prognosis.
  Tissue Antigens 06/2006; 67(5):409-14. · 2.59 Impact Factor